cerca CERCA
Domenica 07 Agosto 2022
Aggiornato: 20:54
Temi caldi


comunicato stampa

Professor Lars Iversen joins MC2 Therapeutics as new Chief Medical Officer

COPENHAGEN, June 9, 2022 /PRNewswire/ -- MC2 Therapeutics A/S, a commercial stage pharmaceutical company, has named Lars Iversen, MD, DMSc an esteemed chair professor in dermatology at Aarhus University Hospital and at Aarhus University, its new full-time Chief Medical Officer (CMO) as of October 1st, 2022.

comunicato stampa


LONDON, June 1, 2022 /PRNewswire/ -- The GSMA has appointed Lara Dewar as Chief Marketing Officer (CMO). Ms. Dewar starts effective from 1st June and will report to GSMA Director General, Mats Granryd. The move follows Ms. Dewar's delivery of strategic reputational and corporate communications for the GSMA as Global Head of PR and Communications.

comunicato stampa

Bitget Appoints Gracy Chen as Managing Director

SINGAPORE, June 1, 2022 /PRNewswire/ -- Leading global derivatives exchange - Bitget, today announced the appointment of Gracy Chen as Managing Director, who will lead Bitget's growth strategies as the platform accelerates its global expansion plan. She will also be elevating Bitget's voice and presence in the broader crypto ecosystem and assisting the brand to further flourish under her leadership.

comunicato stampa

Risen Energy Brings Latest 210mm-based Rooftop Solar Module to Intersolar Europe 2022

NINGBO, China, May 19, 2022 /PRNewswire/ -- Risen Energy ("the Company"), a leading solar module manufacturer in China, participated in Intersolar Europe 2022 where its whole suite of latest solar solutions was on full display from May 11 to 13. Among the products showcased at booth A1.260, RSM130-8-430-450M took center stage as the newest member of Risen Energy's TITAN family. The residential photovoltaic (PV) module inherits the state-of-the-art technologies from the TITAN series while featurin...

comunicato stampa

BioVaxys Confirms First Clinical Site and Principal Investigators for Ovarian Cancer Vaccine Trial and Enters into Second Tumor Cell Supply Agreement

VANCOUVER, BC, May 18, 2022 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV; FRA: 5LB; OTCQB: BVAXF) ("BioVaxys" or "Company"), announced today that Hospices Civils de Lyon, France ("HCL") has agreed to serve as a clinical study site for the Phase I study of BVX-0918, the Company's autologous haptenized tumor cell vaccine for late-stage ovarian cancer. HCL has further agreed to supply BioVaxys with surgically debulked tumors from Stage III/Stage IV ovarian cancer patients undergoing treatmen...

comunicato stampa

Impact Minds: Standing Together, the Latimpacto event that focuses on promoting more social and environmental investment in Latin America

BOGOTÁ, Colombia, May 13, 2022 /PRNewswire/ -- Impact Minds: Standing Together included the participation of actors such as Larry Sacks, Mission Director at USAID Colombia; Juan Carlos Mora, president of Bancolombia; and Sandra Breka, CEO of Bosch Foundation. Drawing from their leadership roles, they inspired more than 350 participants from 25 countries representing Latin America, Europe, Asia, and Africa, including organizations such as impact funds, foundations, family offices, corporations, am...

comunicato stampa

Brian Borack Joins Customertimes as Chief Operating Officer

NEW YORK, May 3, 2022 /PRNewswire/ -- Customertimes, a global Salesforce integration and implementation partner, today announced that veteran technology and software services leader Brian Borack has joined the company as Chief Operating Officer (COO).

comunicato stampa

Huawei Cloud Continues Rapid Growth and Advances Everything as a Service

SHENZHEN, China, April 28, 2022 /PRNewswire/ -- At the Huawei Global Analyst Summit 2022 on April 27, Huawei Cloud delivered a session "Dive into Digital with Everything as a Service", introducing its 2021 business progress, and announced the plan to increase investment in Everything as a Service.

ora in
Prima pagina
in Evidenza